Ondine Biomedical (UK) Analysis

OBI Stock   8.25  0.12  1.48%   
Ondine Biomedical is overvalued with Real Value of 6.52 and Hype Value of 8.16. The main objective of Ondine Biomedical stock analysis is to determine its intrinsic value, which is an estimate of what Ondine Biomedical is worth, separate from its market price. There are two main types of Ondine Biomedical's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Ondine Biomedical's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Ondine Biomedical's stock to identify patterns and trends that may indicate its future price movements.
The Ondine Biomedical stock is traded in UK on London Exchange, with the market opening at 08:00:00 and closing at 16:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in UK. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Ondine Biomedical's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ondine Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Ondine Stock Analysis Notes

About 47.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.03. Ondine Biomedical had not issued any dividends in recent years. To find out more about Ondine Biomedical contact CFA CFA at 604 669 0555 or learn more at https://ondinebio.com.

Ondine Biomedical Quarterly Total Revenue

499,907

Ondine Biomedical Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Ondine Biomedical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Ondine Biomedical or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Ondine Biomedical had very high historical volatility over the last 90 days
Ondine Biomedical has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 1.2 M. Net Loss for the year was (14.41 M) with profit before overhead, payroll, taxes, and interest of 1.25 M.
Ondine Biomedical generates negative cash flow from operations
About 47.0% of the company outstanding shares are owned by corporate insiders
Latest headline from news.google.com: Ondine Biomedical directors update shareholdings post-fundraising - Investing.com

Ondine Biomedical Thematic Classifications

In addition to having Ondine Biomedical stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Drugs Idea
Drugs
Drug manufacturing and delivery

Ondine Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 24.79 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ondine Biomedical's market, we take the total number of its shares issued and multiply it by Ondine Biomedical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

Ondine Biomedical has return on total asset (ROA) of (1.5971) % which means that it has lost $1.5971 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (6.8559) %, meaning that it generated substantial loss on money invested by shareholders. Ondine Biomedical's management efficiency ratios could be used to measure how well Ondine Biomedical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Ondine Biomedical's Non Current Assets Total are projected to decrease significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 7.7 M, whereas Non Currrent Assets Other are forecasted to decline to about 33.2 K.
The decision-making processes within Ondine Biomedical are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Operating Margin
(9.12)
Beta
(0.08)
Return On Assets
(1.60)
Return On Equity
(6.86)

Technical Drivers

As of the 24th of November, Ondine Biomedical holds the Semi Deviation of 3.06, coefficient of variation of 1493.81, and Risk Adjusted Performance of 0.0601. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Ondine Biomedical, as well as the relationship between them. Please check Ondine Biomedical information ratio, value at risk, and the relationship between the standard deviation and treynor ratio to decide if Ondine Biomedical is priced some-what accurately, providing market reflects its current price of 8.25 per share.

Ondine Biomedical Price Movement Analysis

The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Ondine Biomedical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Ondine Biomedical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Ondine Biomedical Outstanding Bonds

Ondine Biomedical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Ondine Biomedical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Ondine bonds can be classified according to their maturity, which is the date when Ondine Biomedical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Ondine Biomedical Predictive Daily Indicators

Ondine Biomedical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Ondine Biomedical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Ondine Biomedical Forecast Models

Ondine Biomedical's time-series forecasting models are one of many Ondine Biomedical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ondine Biomedical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Ondine Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Ondine Biomedical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ondine shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Ondine Biomedical. By using and applying Ondine Stock analysis, traders can create a robust methodology for identifying Ondine entry and exit points for their positions.
Ondine Biomedical is entity of United Kingdom. It is traded as Stock on LSE exchange.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Ondine Biomedical to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Equity Search Now

   

Equity Search

Search for actively traded equities including funds and ETFs from over 30 global markets
All  Next Launch Module

Complementary Tools for Ondine Stock analysis

When running Ondine Biomedical's price analysis, check to measure Ondine Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ondine Biomedical is operating at the current time. Most of Ondine Biomedical's value examination focuses on studying past and present price action to predict the probability of Ondine Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ondine Biomedical's price. Additionally, you may evaluate how the addition of Ondine Biomedical to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Stocks Directory
Find actively traded stocks across global markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Commodity Directory
Find actively traded commodities issued by global exchanges